SC
Stempoint Capital Portfolio holdings
AUM
$583M
1-Year Est. Return
185.08%
This Fund
S&P 500
1 Year Est. Return
+185.08%
AUM
$496M
AUM Growth
+$185M
(+60%)
Holding
92
Top Buys
| 1 | +$44.5M | |
| 2 | +$14.8M | |
| 3 | +$12.3M | |
| 4 |
Wave Life Sciences
WVE
|
+$9.79M |
| 5 |
argenx
ARGX
|
+$8.22M |
Top Sells
| 1 | +$16.6M | |
| 2 | +$14M | |
| 3 | +$13.7M | |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$13.2M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 99.22% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Roivant Sciences
ROIV
$20.5B
| $63.5M | 12.81% |
4,197,187
+3,595,406
|
|
||
2
uniQure
QURE
$579M
| $30.5M | 6.15% |
522,155
-50,460
|
|
||
3
Scholar Rock
SRRK
$4.62B
| $27M | 5.45% |
726,204
+198,089
|
|
||
4
Immunovant
IMVT
$5.51B
| $25.6M | 5.17% |
1,589,580
+288,720
|
|
||
5
Denali Therapeutics
DNLI
$3.14B
| $25.2M | 5.08% |
1,734,659
+1,026,744
|
|
||
|
6
Syndax Pharmaceuticals
SNDX
$1.87B
| $21M | 4.24% |
1,366,205
-1,006,429
|
|
||
|
CNTA
7
Centessa Pharmaceuticals
CNTA
$3.95B
| $15.9M | 3.2% |
655,385
-610,287
|
|
||
|
8
Wave Life Sciences
WVE
$2.53B
| $15.4M | 3.11% |
2,110,152
+1,209,814
|
|
||
9
Biohaven
BHVN
$1.41B
| $15.3M | 3.08% |
1,017,311
+842,557
|
|
||
|
CDTX
10
DELISTED
Cidara Therapeutics
CDTX
| $14.6M | 2.94% |
152,325
-114,449
|
|
||
|
ABVX
11
Abivax
ABVX
$9.19B
| $14.1M | 2.85% |
166,273
+78,525
|
|
||
12
IDEAYA Biosciences
IDYA
$3.03B
| $10.1M | 2.04% |
371,825
+205,940
|
|
||
13
Rhythm Pharmaceuticals
RYTM
$5.98B
| $9.23M | 1.86% |
91,444
-85,308
|
|
||
|
14
argenx
ARGX
$46.3B
| $9.19M | 1.85% |
+12,465
|
|
||
15
Surrozen
SRZN
$234M
| $9.19M | 1.85% |
713,463
+26,924
|
|
||
16
Revolution Medicines
RVMD
$19.6B
| $8.66M | 1.75% |
+185,380
|
|
||
17
Rezolute
RZLT
$319M
| $8.63M | 1.74% |
917,630
+272,976
|
|
||
18
GH Research
GHRS
$966M
| $7.8M | 1.57% |
545,275
+444,449
|
|
||
19
Arcutis Biotherapeutics
ARQT
$2.94B
| $7.76M | 1.57% |
411,893
+206,221
|
|
||
20
VistaGen Therapeutics
VTGN
$25.6M
| $7.75M | 1.56% |
2,488,685
+75,431
|
|
||
21
Xenon Pharmaceuticals
XENE
$3.31B
| $7.72M | 1.56% |
+192,295
|
|
||
22
Alkermes
ALKS
$4.81B
| $7.25M | 1.46% |
241,637
-109,487
|
|
||
23
Celcuity
CELC
$5.04B
| $6.75M | 1.36% |
+136,710
|
|
||
24
BridgeBio Pharma
BBIO
$12.7B
| $6.62M | 1.33% |
127,435
+72,805
|
|
||
25
Insmed
INSM
$32B
| $6.25M | 1.26% |
43,419
-18,159
|
|